When Aardvark Therapeutics announced earlier this month that it was pausing a phase 3 trial of its lead metabolic candidate, ...

Qatar’s exports of natural gas and helium—the latter essential for MRI scans—were effectively halted after Iran closed the Strait of Hormuz and attacked one of the world’s largest production ...

Last year’s funding cuts at the National Institutes of Health (NIH) disproportionately impacted women and early-career researchers, according to a new analysis, raising questions about what the future ...

Stryker continues to dig itself out of the hole left by the global cyberattack it suffered nearly two weeks ago, saying its medical device manufacturing capacity is “ramping quickly as cr | Stryker ...

Sanofi has returned to T-cell engager (TCE) territory via an agreement to pay $180 million in the near term for a phase 1-stage trispecific antibody from Kali Therapeutics. The California biotech took ...

Apogee Therapeutics has published phase 2 eczema data that suggest its anti-IL-13 antibody is a threat to Eli Lilly, Regeneron and Sanofi, prompting analysts to double their peak sales forecast to $5.

Pfizer and Valneva have blamed “fewer than anticipated” Lyme disease cases for the failure of their phase 3 trial to hit its ...

When Ron Cohen, M.D., CEO of Oryon Cell Therapies, recently dug into the company’s Parkinson’s disease data, he told Fierce Biotech it “sang” to him. | When Ron Cohen, M.D., CEO of Oryon Cell ...

Genentech is halting development of an antibody for two rare genetic diseases after the candidate failed to boost muscle growth, raising questions about whether the molecule can preserve muscle in two ...

Intuitive Surgical is recalling one set of its stapler reloads used by its da Vinci robot after incomplete deliveries failed to properly close blood vessels during procedures.  | This comes in the ...

Since Xaira’s eye-popping $1 billion fundraise in 2024, the company has said relatively little in public. | What has Xaira been doing since its $1 billion raise? Xaira COO Jeff Jonker joins "The Top ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...